taurine has been researched along with Myelodysplastic Syndromes in 1 studies
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reikvam, H | 1 |
| Bruserud, Ø | 1 |
| Hatfield, KJ | 1 |
1 other study available for taurine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Pretransplant systemic metabolic profiles in allogeneic hematopoietic stem cell transplant recipients - identification of patient subsets with increased transplant-related mortality.
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Leukemia, Myel | 2023 |